Ward 1 - Edinburgh Cancer Centre, Western General Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lauder, Christen
NXP900-101, NCT05873686: A Phase 1 Clinical Study of NXP900 in Subjects with Advanced Cancers

Recruiting
1
40
Europe, US
NXP900
Nuvectis Pharma, Inc.
Advanced Solid Tumor
01/25
04/25

Download Options